Samsara BioCapital, LLC

Q2 2025 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    29

  • Value ($000)

    $488,945

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
80706P103
$198.81M
41 %

5,612,896

MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$76.78M
16 %

5,674,916

---

SEPTERNA INC

COM
81734D104
$33.29M
7 %

3,149,128

---

KALARIS THERAPEUTICS INC

COM
482929106
$30.57M
6 %

11,448,081

NGNE
NGNE

NEUROGENE INC

COM
64135M105
$25.67M
5 %

1,717,127

CRGX
CRGX

CARGO THERAPEUTICS INC

COM
14179K101
$18.19M
4 %

4,415,689

---

UPSTREAM BIO INC

COM
91678A107
$15.85M
3 %

1,443,231

ALMS
ALMS

ALUMIS INC

COM
022307102
$14.40M
3 %

4,801,370

LENZ
LENZ

LENZ THERAPEUTICS INC

COM
52635N103
$10.05M
2 %

343,012

---

PALVELLA THERAPEUTICS INC NE

COM
697947109
$7.66M
2 %

339,743

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 29